Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2024
Stefanie S, Koldehoff M, Schenk-Westkamp P, Horn PA, Esser S, Lindemann M. T Cell Responses against Orthopoxviruses in HIV-Positive Patients. Vaccines (Basel). 2024;12(2).
Mahadeo KMichael, Baiocchi R, Beitinjaneh A, Chaganti S, Choquet S, Dierickx D, Dinavahi R, Duan X, Gamelin L, Ghobadi A, et al. Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicent. Lancet Oncol. 2024.
Baudic M, Murata H, Bosada FM, Melo USouto, Aizawa T, Lindenbaum P, van der Maarel LE, Guedon A, Baron E, Fremy E, et al. TAD boundary deletion causes PITX2-related cardiac electrical and structural defects. Nat Commun. 2024;15(1):3380.
Pirosa MCristina, Stathis A, Zucca E. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma. Hum Vaccin Immunother. 2024;20(1):2309701.
Damhofer H, Tatar T, Southgate B, Scarneo S, Agger K, Shlyueva D, Uhrbom L, Morrison GM, Hughes PF, Haystead T, et al. TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell Death Dis. 2024;15(4):273.
Wilkinson AC. Take the MYC to expand blood stem cells. Blood. 2024;143(10):838-840.
Seclen E, Jang JC, Lawal AO, Pulicani S, Boyne A, Tkach D, Juillerat A, Duchateau P, Valton J. TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage. Mol Ther. 2024.
Barajas JM, Umeda M, Contreras L, Khanlari M, Westover T, Walsh MP, Xiong E, Yang C, Otero B, Arribas-Layton M, et al. tandem duplications in pediatric myelodysplastic syndrome and acute myeloid leukemia: implications for clinical screening and diagnosis. Haematologica. 2024.
Hoang C, Uritboonthai W, Hoang L, Billings EM, Aisporna A, Nia FA, Derks RJE, Williamson JR, Giera M, Siuzdak G. Tandem Mass Spectrometry across Platforms. Anal Chem. 2024.
Jiang X, Zhu W, Sun Y, Wang S, Sun M, Tang R, Tang Z, Ma T. Tandem mass tag-based quantitative proteomics analyses of the spermatogenesis-ameliorating effect of Youjing granule on rats. Rapid Commun Mass Spectrom. 2024;38(3):e9679.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, et al. TANGO1 inhibitors reduce collagen secretion and limit tissue scarring. Nat Commun. 2024;15(1):3302.
Zhao L-L, Luo J-J, Cui J, Li X, Hu R-N, Xie X-Y, Zhang Y-J, Ding W, Ning L-J, Luo J-C, et al. Tannic Acid-Modified Decellularized Tendon Scaffold with Antioxidant and Anti-Inflammatory Activities for Tendon Regeneration. ACS Appl Mater Interfaces. 2024.
Yang J, Gong X, Li T, Xia Z, He R, Song X, Wang X, Wu J, Chen J, Wang F, et al. Tantalum Particles Promote M2 Macrophage Polarization and Regulate Local Bone Metabolism via Macrophage-Derived Exosomes Influencing the Fates of BMSCs. Adv Healthc Mater. 2024:e2303814.
Wang Q, Zhang R, He Y, Mao G, Kong Z. Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the COX-2/PGE2/JAK2/STAT3/MMP pathway. Int J Radiat Biol. 2024:1-11.
Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024.
Fatima N, Umar M, Ambreen S, Shaququzzaman M, Alam MMumtaz, Ali R. Targeted Cancer Stem Cell Therapeutics: An Update. Curr Top Med Chem. 2024.
Ke F, Benet ZL, Shelyakin P, Britanova OV, Gupta N, Dent AL, Moore BB, Grigorova IL. Targeted checkpoint control of B cells undergoing positive selection in germinal centers by follicular regulatory T cells. Proc Natl Acad Sci U S A. 2024;121(5):e2304020121.
Karbassi E, Padgett R, Bertero A, Reinecke H, Klaiman JM, Yang X, Hauschka SD, Murry CE. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium. Cell Mol Life Sci. 2024;81(1):95.
Jiang Y, Yu M, Song Z-F, Wei Z-Y, Huang J, Qian H-Y. Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment. Int J Nanomedicine. 2024;19:2553-2571.
Zhang Z, Zhang S, Wong HTing, Li D, Feng B. Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight. BioDrugs. 2024.
Glaser KM, Egg M, Hobitz S, Mitterer M, Schain-Zota D, Schönberger K, Schuldes K, Cabezas-Wallscheid N, Lämmermann T, Rambold A, et al. Targeted Metabolomics on Rare Primary Cells. J Vis Exp. 2024;(204).
de Vries ISNaarmann, Dieterich C. Targeted Sequencing of Circular RNAs for Illumina-Based Counting and Nanopore Structure Determination. Methods Mol Biol. 2024;2765:127-142.
Eichholz T, Heubach F, Arendt A-M, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, et al. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3. Cancer Immunol Immunother. 2024;73(1):19.
Yang Q, Gao W, Li X, Li X, Zhou X, Li W, Zhou C, Luo A, Liu Z. Targeting ABCA1 via Extracellular vesicle-Encapsulated Staurosporine as a Therapeutic Strategy to enhance Radiosensitivity. Adv Healthc Mater. 2024:e2400381.
Chen X, Sun X, Ge Y, Zhou X, Chen J-F. Targeting adenosine A receptors for early intervention of retinopathy of prematurity. Purinergic Signal. 2024.

Pages